Folkerd E - Search Results

1

Molecular profiling of aromatase inhibitor sensitive and resistant ER+HER2- postmenopausal breast cancers.

Schuster EF, Lopez-Knowles E, Alataki A, Zabaglo L, Folkerd E, Evans D, Sidhu K, Cheang MCU, Tovey H, Salto-Tellez M, Maxwell P, Robertson J, Smith I, Bliss JM, Dowsett M. Schuster EF, et al. Among authors: folkerd e. Nat Commun. 2023 Jul 7;14(1):4017. doi: 10.1038/s41467-023-39613-z. Nat Commun. 2023. PMID: 37419892 Free PMC article.

2

Deficits in plasma oestradiol measurement in studies and management of breast cancer.

Dowsett M, Folkerd E. Dowsett M, et al. Among authors: folkerd e. Breast Cancer Res. 2005;7(1):1-4. doi: 10.1186/bcr960. Epub 2004 Oct 28. Breast Cancer Res. 2005. PMID: 15642174 Free PMC article. Review.

3

The biology of steroid hormones and endocrine treatment of breast cancer.

Dowsett M, Folkerd E, Doody D, Haynes B. Dowsett M, et al. Among authors: folkerd e. Breast. 2005 Dec;14(6):452-7. doi: 10.1016/j.breast.2005.08.019. Epub 2005 Sep 28. Breast. 2005. PMID: 16198110 Review.

4

Caution: Vaginal estradiol appears to be contraindicated in postmenopausal women on adjuvant aromatase inhibitors.

Kendall A, Dowsett M, Folkerd E, Smith I. Kendall A, et al. Among authors: folkerd e. Ann Oncol. 2006 Apr;17(4):584-7. doi: 10.1093/annonc/mdj127. Epub 2006 Jan 27. Ann Oncol. 2006. PMID: 16443612 Free article.

5

The relationship between factors affecting endogenous oestradiol levels in postmenopausal women and breast cancer.

Folkerd EJ, Martin LA, Kendall A, Dowsett M. Folkerd EJ, et al. J Steroid Biochem Mol Biol. 2006 Dec;102(1-5):250-5. doi: 10.1016/j.jsbmb.2006.09.024. Epub 2006 Oct 17. J Steroid Biochem Mol Biol. 2006. PMID: 17049846 Review.

6

Influences on circulating oestrogens in postmenopausal women: relationship with breast cancer.

Kendall A, Folkerd EJ, Dowsett M. Kendall A, et al. J Steroid Biochem Mol Biol. 2007 Feb;103(2):99-109. doi: 10.1016/j.jsbmb.2006.07.011. Epub 2006 Nov 7. J Steroid Biochem Mol Biol. 2007. PMID: 17088056 Review.

7

Suppression of ovarian function in combination with an aromatase inhibitor as treatment for advanced breast cancer in pre-menopausal women.

Cheung KL, Agrawal A, Folkerd E, Dowsett M, Robertson JF, Winterbottom L. Cheung KL, et al. Among authors: folkerd e. Eur J Cancer. 2010 Nov;46(16):2936-42. doi: 10.1016/j.ejca.2010.08.005. Epub 2010 Sep 9. Eur J Cancer. 2010. PMID: 20832294

8

Fulvestrant plus anastrozole or placebo versus exemestane alone after progression on non-steroidal aromatase inhibitors in postmenopausal patients with hormone-receptor-positive locally advanced or metastatic breast cancer (SoFEA): a composite, multicentre, phase 3 randomised trial.

Johnston SR, Kilburn LS, Ellis P, Dodwell D, Cameron D, Hayward L, Im YH, Braybrooke JP, Brunt AM, Cheung KL, Jyothirmayi R, Robinson A, Wardley AM, Wheatley D, Howell A, Coombes G, Sergenson N, Sin HJ, Folkerd E, Dowsett M, Bliss JM; SoFEA investigators. Johnston SR, et al. Among authors: folkerd e. Lancet Oncol. 2013 Sep;14(10):989-98. doi: 10.1016/S1470-2045(13)70322-X. Epub 2013 Jul 29. Lancet Oncol. 2013. PMID: 23902874 Free article. Clinical Trial.

9

Sex hormones and breast cancer risk and prognosis.

Folkerd E, Dowsett M. Folkerd E, et al. Breast. 2013 Aug;22 Suppl 2:S38-43. doi: 10.1016/j.breast.2013.07.007. Breast. 2013. PMID: 24074790 Free article. Review.

10

Reduced progesterone levels explain the reduced risk of breast cancer in obese premenopausal women: a new hypothesis.

Dowsett M, Folkerd E. Dowsett M, et al. Among authors: folkerd e. Breast Cancer Res Treat. 2015 Jan;149(1):1-4. doi: 10.1007/s10549-014-3211-4. Epub 2014 Nov 21. Breast Cancer Res Treat. 2015. PMID: 25414027 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

84 results

Search Page